Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (52.540)

1

Influence of pathogenic filaggrin variants on dupilumab treatment in atopic dermatitis

enthalten in: The Journal of allergy and clinical immunology | 2024

von Clabbers, J. | Boesjes, C. | Spekhorst, L. | +11

2

Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding factor acute myeloid leukemia

enthalten in: Leukemia research | 2024

von Bourne, G. | Diebold, K. | Espinoza-Gutarra, M. | +6

3

Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60) : a randomised, non-comparative, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von Kim, S. | Ghiringhelli, F. | de la Fouchardière, C. | +25

4

Treatment patterns of galcanezumab versus standard of care preventive migraine medications over 24 months : a US retrospective claims study

enthalten in: Current medical research and opinion | 2024

von Varnado, O. | Vu, M. | Buysman, E. | +6

5

Eculizumab in STEC-HUS with severe neurological involvement : a New Zealand perspective

enthalten in: Pediatric nephrology (Berlin, Germany) | 2024

von Selvathesan, N. | Wong, W. | Prestidge, C.

6

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Smit, E. | Felip, E. | Uprety, D. | +17

7

Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease

enthalten in: Journal of pediatric gastroenterology and nutrition | 2024

von Rowland, P. | McNicol, M. | Kiel, A. | +5

8

Sugemalimab with chemotherapy for advanced ESCC

enthalten in: Nature reviews. Gastroenterology & hepatology | 2024

von Ray, K.

9

Real-world management of patients with neuromyelitis optica spectrum disorder using satralizumab : Results from a Japanese claims database

enthalten in: Multiple sclerosis and related disorders | 2024

von Nakashima, I. | Nakahara, J. | Yasunaga, H. | +5

10

Letter in reply : network meta-analysis for indirect comparison of lanadelumab and for the treatment of hereditary angioedema

enthalten in: Journal of comparative effectiveness research | 2024

von Watt, M. | Malmenas, M. | Haeussler, K.

CommentOn: J Comp Eff Res. 2024 May;13(5):e230165. - PMID 38545965

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[5254]